Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
General Electric
Philips Healthcare
Information provided by (Responsible Party):
Hero Hussain, MD, University of Michigan
ClinicalTrials.gov Identifier:
NCT00738712
First received: August 19, 2008
Last updated: December 15, 2016
Last verified: December 2016

August 19, 2008
December 15, 2016
May 2011
December 2018   (Final data collection date for primary outcome measure)
Evaluation of new software in MRI vascular imaging [ Time Frame: 1 year ]
New software technology will be utilized to enhance MRI imaging of the vascular regions of the body.
Not Provided
Complete list of historical versions of study NCT00738712 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Healthy
Procedure: MRI Magnetic Resonance Imaging
MRI
Other Name: Magnetic Resonance Imaging
Experimental: New MRI techniques
New hardware or software technologies designed to improve MRI (Magnetic Resonance Imaging) exams.
Intervention: Procedure: MRI Magnetic Resonance Imaging
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
20
December 2019
December 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • male or non-pregnant female patient
  • 18 years or older
  • any ethnic background
  • presenting to MRI for a clinically-ordered chest MRI exam.

Exclusion Criteria:

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • Pregnant patients or patients who are lactating.
  • A patient who is claustrophobic
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00738712
HUM00041815
Yes
Not Provided
No
Not Provided
Hero Hussain, MD, University of Michigan
University of Michigan
  • General Electric
  • Philips Healthcare
Principal Investigator: Hero Hussain, MD University of Michigan
University of Michigan
December 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP